<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The insulin-like growth factor (IGF) pathway and visceral <z:hpo ids='HP_0001513'>obesity</z:hpo> have been independently linked with <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to delineate the differential and interlinked role of visceral <z:hpo ids='HP_0001513'>obesity</z:hpo> and the IGF-1 system in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and esophageal <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: IGF-1 receptor (IGF-1R) <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein were examined in esophageal <z:mp ids='MP_0004207'>SCC</z:mp> (KYSE 410, OE21) and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (OE19, OE33) cell lines by western blotting </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cell proliferation in response to IGF-1 was assessed by bromodeoxyuridine incorporation assay </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C0014859" disease_type="Neoplastic Process" abbrv="">esophageal tumor</z:e> sections, expression of IGF-1R and CD68(+) cell numbers were assessed by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>IGF-1 was measured in serum from <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> patients, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> patients, and healthy controls by enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Higher IGF-1R protein expressions were observed in <z:mp ids='MP_0004207'>SCC</z:mp> cells compared with esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells however only <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines significantly increased proliferation in response to IGF-1 (P&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Serum IGF-1 levels were highest in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients (P&lt;0.01) and higher in viscerally <z:mp ids='MP_0001261'>obese</z:mp> vs. nonobese (P&lt;0.05) patients </plain></SENT>
<SENT sid="8" pm="."><plain>In resected <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, increased expression of IGF-1R was observed in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and invasive edge compared with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated stroma (P&lt;0.05), which coincided with increased CD68(+) cells in stromal tissue surrounding invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> edge (P&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This novel study examined the differential role of the IGF system in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and <z:mp ids='MP_0004207'>SCC</z:mp>, and its association with visceral <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>These results indicate that the IGF-1 axis has a key role in malignant progression of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, and represents a plausible mechanism through which visceral <z:hpo ids='HP_0001513'>obesity</z:hpo> impacts on esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> risk and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology </plain></SENT>
</text></document>